These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Filgrastim. A review of its pharmacological properties and therapeutic efficacy in neutropenia. Frampton JE, Lee CR, Faulds D. Drugs; 1994 Nov; 48(5):731-60. PubMed ID: 7530630 [Abstract] [Full Text] [Related]
9. Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial. Maher DW, Lieschke GJ, Green M, Bishop J, Stuart-Harris R, Wolf M, Sheridan WP, Kefford RF, Cebon J, Olver I, McKendrick J, Toner G, Bradstock K, Lieschke M, Cruickshank S, Tomita DK, Hoffman EW, Fox RM, Morstyn G. Ann Intern Med; 1994 Oct 01; 121(7):492-501. PubMed ID: 7520676 [Abstract] [Full Text] [Related]
10. A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Dale DC, Bonilla MA, Davis MW, Nakanishi AM, Hammond WP, Kurtzberg J, Wang W, Jakubowski A, Winton E, Lalezari P. Blood; 1993 May 15; 81(10):2496-502. PubMed ID: 8490166 [Abstract] [Full Text] [Related]
11. Lymphoproliferative disorder of granular lymphocytes associated with severe neutropenia. Response to granulocyte colony-stimulating factor. Cooper DL, Henderson-Bakas M, Berliner N. Cancer; 1993 Sep 01; 72(5):1607-11. PubMed ID: 7688654 [Abstract] [Full Text] [Related]
12. Subcutaneous versus intravenous granulocyte colony stimulating factor for the treatment of neutropenia in hospitalized hemato-oncological patients: randomized controlled trial. Paul M, Ram R, Kugler E, Farbman L, Peck A, Leibovici L, Lahav M, Yeshurun M, Shpilberg O, Herscovici C, Wolach O, Itchaki G, Bar-Natan M, Vidal L, Gafter-Gvili A, Raanani P. Am J Hematol; 2014 Mar 01; 89(3):243-8. PubMed ID: 24178750 [Abstract] [Full Text] [Related]
13. CD3+CD4-CD8+NK- large granular lymphocytosis with neutropenia and evidence for clonality and T-cell receptor gene rearrangement: two pediatric cases. Krishna MT, Hodges E, Lavender FL, Harris S, Gennery A, Cant A, Gibson B, Wilkie R, Darbyshire P, Smith JL. J Pediatr Hematol Oncol; 2002 Mar 01; 24(6):495-8. PubMed ID: 12218601 [Abstract] [Full Text] [Related]
14. Filgrastim to treat neutropenia and support myelosuppressive medication dosing in HIV infection. G-CSF 92105 Study Group. Hermans P, Rozenbaum W, Jou A, Castelli F, Borleffs J, Gray S, Ward N, Gori A, De Bona A, Ferré C, Loncà M, Lang JM, Ammassari A, Clumeck N. AIDS; 1996 Dec 01; 10(14):1627-33. PubMed ID: 8970682 [Abstract] [Full Text] [Related]
18. Effect of filgrastim (G-CSF) during chemotherapy and abdomino-pelvic radiation therapy in patients with ovarian carcinoma. Fyles AW, Manchul L, Levin W, Robertson JM, Sturgeon J, Tsuji D. Int J Radiat Oncol Biol Phys; 1998 Jul 01; 41(4):843-7. PubMed ID: 9652847 [Abstract] [Full Text] [Related]
19. Inhibition of CFU-GM by prostaglandins in a case of chronic T-cell lymphocytosis and neutropenia. Smith JG, Smith MA, James I, Blundell E, Maddison PJ. Br J Haematol; 1989 Oct 01; 73(2):148-51. PubMed ID: 2818937 [Abstract] [Full Text] [Related]
20. Effects of the in vivo administration of recombinant human granulocyte colony-stimulating factor following cytotoxic chemotherapy on granulocytic precursors in patients with malignant lymphoma. Ema H, Suda T, Sakamoto S, Tomonaga T, Tsunoda J, Muroi K, Komatsu N, Miwa A, Ohsaka A, Yoshida M. Jpn J Cancer Res; 1989 Jun 01; 80(6):577-82. PubMed ID: 2474526 [Abstract] [Full Text] [Related] Page: [Next] [New Search]